Electron paramagnetic resonance has been used to measure in-cell distances between spin labels with higher sensitivity than previously seen for conversional methods.
Researchers have discovered a difference between radiation-sensitive and radiation-resistant tumors that could be utilized to assess tumor response, potentially sparing some patients of the toxic side effects of ineffective radiation therapy.
You are cordially invited to join us in New Orleans for an exclusive masquerade ball celebrating all things bioanalysis!
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.
Researchers from the University of Strathclyde (Glasgow, UK) have developed a new biomarker test that could diagnose sepsis in under 3 minutes.
Charles River Laboratories have signed an agreement to acquire Citoxlab for $510 million in a deal that aims to expand their global scale and scientific service portfolio.
Researchers have developed a new diagnostic technique to accurately differentiate bladder cancer from benign inflammation using AHNAK2 protein biomarkers.
In this short article one of the organisers of the 23rd International Reid Bioanalytical Forum, Tim Sangster, discusses what this year’s conference has in store from scientific content to social activities.
A novel protein has been discovered that could be a useful blood-based biomarker to monitor the progression of inherited Alzheimer’s disease, over a decade before the clinical symptoms appear.
Researchers from Queen’s University Belfast (UK) have developed a new enzyme biomarker test that has the potential to detect disease and infection.